Astria Therapeutics, Inc. Restructuring Charges
Astria Therapeutics, Inc. reported Restructuring Charges of $0 for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2018-11-13
- Astria Therapeutics, Inc. restructuring charges for the quarter ending 2018-09-30 was $0.00.
- Astria Therapeutics, Inc. restructuring charges for the quarter ending 2018-06-30 was $900.00K.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month |
|---|---|---|---|
| 2018-09-30 | $0.00 10-Q · filed 2018-11-13 | $900.00K derived: sum of 2 quarters · filed 2018-11-13 | $900.00K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $900.00K 10-Q · filed 2018-08-09 |